Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives.

ABSTRACT: Cancer associated fibroblasts are a prominent component of the tumour microenvironment in most solid cancers. This heterogeneous population of cells are known to play an important role in tumour progression and recent studies have demonstrated that CAFs may confer resistance to checkpoint immunotherapy, suggesting that targeting these cells could improve response rates. However, effective clinical strategies for CAF targeting have yet to be identified. In this editorial, we highlight current limitations in our understanding of CAF heterogeneity, and discuss the potential and possible approaches for CAF-directed therapy.

SUBMITTER: Hanley CJ 

PROVIDER: S-EPMC8274722 | biostudies-literature |

REPOSITORIES: biostudies-literature